Prescription drug companies' obscene price gouging is leaving patients without access to lifesaving medical treatments. I've got a plan to lower costs on several key drugs that millions rely on. Here are just a few examples.
Insulin was discovered nearly 100 years ago as a treatment for diabetes. But three drug companies dominated the market and jacked up prices. Now, Americans with diabetes are rationing their insulin—and taxpayers are spending billions on it through Medicare and Medicaid. 
EpiPens deliver life-saving doses of epinephrine, a drug that reverses severe allergic reactions to things like peanuts and bee stings. In 2016, EpiPens’ manufacturer jacked up prices by 400%, leaving families unable to afford this life-saving medication.
Health officials agree that naloxone is critical to curbing the opioid epidemic, and it can be as cheap as 5¢ a dose. But one company spiked the price of their product by over 550% to “capitalize on the opportunity” of the opioid crisis.
Humira is used by millions of patients around the world to treat diseases like arthritis, psoriasis, and Crohn’s disease. But its manufacturer, AbbVie, doubled its price—and used blatantly anti-competitive behavior to prevent a competitor from entering the market.
Truvada’s manufacturer, Gilead, relied on $50 million in federal grants to develop it, but today they rake in multi-billion dollar profits while Americans struggle to afford it. Only a fraction of patients benefit from it, thanks to its hefty $2,000-a-month price tag.
Harvoni is described as a "miracle" drug, but it's $94,500-per-treatment price tag leaves 85% of the more than 3 million Americans living with Hepatitis C unable to use it, while taxpayers foot a $3.8 billion bill.
No more rationing insulin. No more cutting pills. No more going without. On day one as president, I'll immediately act to lower the cost of prescription drugs. And by the end of my first term, we'll move to fully transition to #MedicareForAll. ewar.ren/M4A-Transition
